drugset / Press release
GSK enters agreement to obtain exclusive license for JNJ-3989 to expand the development of bepirovirsen
2023-10-31 · Arrowhead Pharmaceuticals · original arrowheadpharma.com ↗
You are now being redirected Are you sure you want to leave this site? Continue Cancel
The release as fetched from its publisher. arrowheadpharma.com ↗